Recombinant Adenovirus Vaccines Can Successfully Elicit CD8+ T Cell Immunity under Conditions of Extreme Leukopenia (Q56980888)

5

object named as

Galina Denisova

0 references

author name string

Natalie Grinshtein

1

0 references

Teng-Chih Yang

2

0 references

Robin Parsons

3

0 references

James Millar

4

0 references

Dilan Dissanayake

6

0 references

Jaina Leitch

7

0 references

Yonghong Wan

T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review

8

0 references

publication date

February 2006

0 references

published in

Molecular Therapy

0 references

volume

13

0 references

issue

2

0 references

page(s)

270-279

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Tumor immunity and autoimmunity induced by immunization with homologous DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Coupling and uncoupling of tumor immunity and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Adenoviruses as vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Detailed analysis of the CD8+ T-cell response following adenovirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Contribution of host radioresistant T cells to the clonal elimination of minor lymphocyte stimulatory-1a reactive T cells in mouse bone marrow chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

T cell homeostatic proliferation elicits effective antitumor autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Memory CD8 T-cell differentiation during viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

CD8+ T cell cross-priming via transfer of proteasome substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Langerhans cells renew in the skin throughout life under steady-state conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

T cell receptor antagonist peptides induce positive selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.018